Dose-Chek™ v2.0
SUPPORTS DRUG DOSE SCREENING
Dose-Chek™ v2.0 supports dose and duration of therapy screening for both prescription and nonprescription drug products. The information provided in Dose-Chek™ v2.0 is comprehensive and age-specific. Cost of therapy can be determined when used in combination with pricing information from Master Drug Data Base v2.5 (MDDB®).
FEATURES
- Minimum and maximum single and daily dose ranges for infant and pediatric patients
- Minimum, maximum, and usual single and daily dose ranges for adult and geriatric patients
- Minimum and maximum duration of therapy ranges for infant and pediatric patients
- Minimum, maximum and usual duration of therapy dose ranges for adult and geriatric patients
BENEFITS
FOR PAYERS
- Supports cost of therapy determinations
- Screens for potentially inappropriate dosing or therapy duration
- Supports prospective, concurrent and retrospective Drug Utilization Review (DUR) screening and analysis
- Improves clinical outcomes by ensuring patients receive the proper medication dosage for the appropriate duration
- Reduces risk of ineffective, toxic or unnecessary dosages
- Reduces cost of unnecessary treatment due to inaccurate dosing or excessive duration
FOR PHARMACISTS
- Supports cost of therapy determinations
- Screens for potentially inappropriate dosing or therapy duration
- Supports prospective, concurrent and retrospective Drug Utilization Review (DUR) screening and analysis
- Improves clinical outcomes by ensuring patients receive the proper medication dosage for the appropriate duration
- Reduces risk of ineffective, toxic or unnecessary dosages
- Reduces cost of unnecessary treatment due to inaccurate dosing or excessive duration
The file is produced and delivered to customers on a weekly, monthly or quarterly basis.